| Not Yet Recruiting | Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabet Type 2 Diabetes (T2DM) | Phase 3 | 2025-08-01 |
| Recruiting | A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 2 | 2025-07-02 |
| Enrolling By Invitation | A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adoles Essential Hypertension | Phase 3 | 2025-02-05 |
| Not Yet Recruiting | Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding Peptic Ulcer Bleeding | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors Advanced Solid Tumors (Phase 1) | Phase 1 | 2025-01-20 |
| Not Yet Recruiting | Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy Colorectal Adenoma | Phase 2 | 2024-12-01 |
| Recruiting | A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction Postoperative Gastrointestinal Dysfunction | Phase 2 | 2024-10-18 |
| Enrolling By Invitation | A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Re Cervical Cancer | Phase 2 / Phase 3 | 2024-09-26 |
| Recruiting | Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria Acute Urticaria | Phase 3 | 2024-04-22 |
| Not Yet Recruiting | Phase I Study of LNF1901 in Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2024-02-01 |
| Not Yet Recruiting | Phase I Study of XZ120 in Malignant Tumors Advanced Malignancies | Phase 1 | 2024-02-01 |
| Completed | Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions Atrial Fibrillation (AF) | N/A | 2023-06-05 |
| Completed | Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans Pruritus | N/A | 2023-05-24 |
| Unknown | A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metasta Non-small Cell Lung Cancer, NSCLC, PD-1 | Phase 2 | 2023-03-01 |
| Completed | Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans Solid Tumor Cancer | N/A | 2022-11-21 |
| Completed | Bioequivalence Study of Dronedarone Hydrochloride Tablets Atrial Fibrillation (AF) | N/A | 2022-11-14 |
| Recruiting | the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2022-11-11 |
| Unknown | A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis Osteoporosis | Phase 3 | 2022-05-31 |
| Unknown | Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tu Solid Tumors | Phase 1 / Phase 2 | 2022-05-23 |
| Unknown | Study of F527 in Patients With Relapsed or Refractory Lymphoma Relapsed/Refractory Lymphoma | Phase 1 | 2022-05-20 |
| Unknown | A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL RR DLBCL; PD-1; CD20 | Phase 2 | 2022-01-01 |
| Unknown | Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma | Phase 1 | 2021-07-30 |
| Completed | A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma Cervical Cancer | Phase 2 | 2021-03-04 |
| Unknown | A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma Locally Advanced or Metastatic Urothelial Cell Carcinoma | Phase 2 | 2021-01-01 |
| Unknown | The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL). Peripheral T Cell Lymphoma | Phase 2 | 2020-11-01 |
| Unknown | A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Ne Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma | Phase 2 | 2020-11-01 |
| Unknown | A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B Recruiting | Phase 3 | 2020-10-13 |
| Completed | Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg Bioequivalence | N/A | 2020-10-01 |
| Completed | A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver Efficacy and Safety | Phase 4 | 2020-05-13 |
| Unknown | Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520 Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma | Phase 1 | 2019-03-01 |
| Completed | A Phase IV Study of Huazhi Rougan Granule A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver | Phase 4 | 2017-05-18 |